Sutters.ai maximizes therapeutic value by repackaging stalled clinical candidates and proven commercial drugs into targeted nanocarriers. By solving delivery-driven efficacy and toxicity, we ensure that small and large molecule drugs reach the right place, at the right time, and at the right concentration to unlock new, high-impact indications. We are able to do this by running a wet-lab data factory, capable of economically creating the data necessary to fuel ai applications.


